Novo’s Wegovy HD passes muster under FDA national priority voucher program
19th March 2026 Uncategorised 0Still basking in the afterglow of its Wegovy pill launch earlier this year, Novo has achieved another victory as it strives to make the most out of its blockbuster GLP-1 drug in an increasingly pressured obesity market.
More: Novo’s Wegovy HD passes muster under FDA national priority voucher program
Source: fierce